IE
IMCR icon

Israel Englander’s Immunocore IMCR Stock Holding History

Israel Englander’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,000
Closed -$471K – 6223
2025
Q2 		$471K Buy
+15,000
New +$466K ﹤0.01% 4952
2023
Q4 		– Sell
-60,000
Closed -$3.11M – 6283
2023
Q3 		$3.11M Sell
60,000
-5,000
-8% -$296K ﹤0.01% 3171
2023
Q2 		$3.9M Hold
65,000
– – ﹤0.01% 2891
2023
Q1 		$3.21M Buy
65,000
+7,000
+12% +$394K ﹤0.01% 2994
2022
Q4 		$3.31M Buy
+58,000
New +$3.26M ﹤0.01% 3132
2022
Q3 		– Sell
-34,100
Closed -$1.27M – 7253
2022
Q2 		$1.27M Buy
34,100
+1,700
+5% +$55.2K ﹤0.01% 4156
2022
Q1 		$969K Buy
+32,400
New +$818K ﹤0.01% 4558

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Israel Englander's IMCR Position: Q2 2026 in Review

Israel Englander increased its Immunocore (IMCR) stake by 29% in Q2 2026, buying an estimated $10.6M and bringing the position to 1,597,037 shares worth $50.7M. The position accounts for 0.02% of the portfolio, ranked #883.

Israel Englander first reported a position in IMCR in Q1 2021 and has held it in 19 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Israel Englander held 1,597,037 shares of Immunocore worth $50.7M as of Q2 2026.
  • Israel Englander bought 359,634 Immunocore shares in Q2 2026, an estimated $10.6M.
  • Immunocore made up 0.02% of Israel Englander's portfolio in Q2 2026, its #883 holding.
  • Israel Englander first reported a position in Immunocore in Q1 2021 and has held it in 19 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.